Genomics is undeniably medicine’s future, and genomics stocks stand to be the next big thing in healthcare as the industry matures. But the crux of the matter is when the industry will mature. Medical ...

10x Genomics (NASDAQ:TXG) has been analyzed by 12 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below offers a condensed view of their ...

Dr. Linda Genen named CMO to further strengthen GeneDx’s commitment to delivering earlier answers and better outcomes through ...

Few would deny that we are living in an AI Spring, yet many of the most popular advances have been in areas that are of marginal importance. While Large Language Models, chatbots, and generative ...

John Halamka, MD, was just the second human being to be sequenced in the landmark Personal Genome Project in 2008, one of the initial group of volunteers known as the PGP-10. Back then, it cost about ...

Many of today's most advanced tools in medicine are not designed for the real-world clinical environments where most of the global population receives care. Vignesh Bageerathan, a genomics innovator ...

A comprehensive genetic investigation led by Dr. Feng Liu at Tianjin Medical University General Hospital has uncovered ...